Monash University researchers have used the world's largest multiple sclerosis (MS) registry, MSBase, to provide evidence that will help those with MS take the best medicine for them. People with MS ...
Two complementary predictors (DAAE-M and ELIE) estimate individualized 5-year progression risk using routine clinical data, extending the prior DAAE framework beyond static baseline risk. Registry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results